secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2023-11-21T23:59:59+00:00
Accession:  0000950170-23-065303
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kintara Therapeutics terminates CSO Dennis Brown; directors defer fees; CEO gets $30K/month retention
--------------------------------------------------------------------------------

- CSO Dennis Brown terminated effective Nov 20, 2023; will continue as consultant at ≤$350/hour month-to-month.
- Board of Directors agrees to defer all director fees indefinitely to reduce costs.
- CEO Robert Hoffman receives retention payment of $30,000 per month starting Nov 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017023065303/0000950170-23-065303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017023065303/ktra-20231120.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-065303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer